Table 2.
CK | Phos | Sodium | GOT | GPT | Leuco | Haematocrit | Hb | Pla | |
---|---|---|---|---|---|---|---|---|---|
cut off | >170 U/L | <0.75 mmol/L | <125 mmol/L | >35 U/L | >35 U/L | <3.98 G/L | <25 % | <11.2 g/L | <182 G/L |
At admission | 222 ± 974 | 1.15 ± 0.29 | 138.7 ± 4.7 | 67.9 ± 117.8 | 85.6 ± 121.9 | 4.1 ± 1.8 | 37.0 ± 5.0 | 12.5 ± 1.8 | 242 ± 81 |
(27–9941) | (0.46–1.92) | (112.0–152.0) | (15.3–1078.0) | (8.3–742.0) | (1.1–14.0) | (22.9–44.7) | (7.5–15.6) | (45–494) | |
After four weeks | 75 ± 54 *** | 1.34 ± 0.18 *** | 141.3 ± 2.7 *** | 25.9 ± 8.0 *** | 42.3 ± 21.6 *** | 4.8 ± 1.8 *** | 36.1 4.2 ** | 11.6 ± 1.5 *** | 300 ± 92 *** |
(22–374) | (0.94–1.88) | (133.0–148.0) | (12.7–53.0) | (10.7–133.0) | (1.6–12.8) | (23.0–42.0) | (6.6–14.3) | (185–849) | |
pathologic at admission | 19 (103) | 7 (103) | 7 (103) | 54 (103) | 62 (103) | 54 (103) | 23 (103) | 21 (103) | 21 (103) |
18.4% | 6.8% | 6.8% | 52.4% | 60.2% | 52.4% | 22.3% | 20.4% | (20.4%) | |
pathologic after four weeks | 6 (103) | 0 (103) | 0 (103) | 12 (103) | 61 (103) | 37 (101) | 22 (101) | 36 (101) | 0 (101) |
5.8% * | 0% * | 0% * | 11.7% *** | 59.2% | 36.6% * | 21.8% | 35.6% * | (0%) *** |
The T-test was used for normally distributed differences in blood values between two measurement points. A Wilcoxon test was used for non-normally distributed differences. For the percentage change in the proportion of pathological blood values, the two-sided Fischer’s exact test was used * p < 0.05; ** p < 0.01;***. p < 0.001; data in parenthesis are ranges. Abbreviations: CK: creatine kinase; Phos: inorganic phosphate; GOT: aspartate aminotransferase; GPT: alanine aminotransferase; Leuco: leukocytes; Hb: hemoglobin; Pla: platelets; SD, standard deviation.